NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Nigel Russell
University of Nottingham - Nottingham / United Kingdom
Medical and Health Sciences / Hematology
AD Scientific Index ID: 1070188
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Nigel Russell's MOST POPULAR ARTICLES
1-)
Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: Presented in part at …CL Sawyers, A Hochhaus, E Feldman, JM Goldman, CB Miller, ...Blood, The Journal of the American Society of Hematology 99 (10), 3530-3539, 200214742002
2-)
Targeting FLT3 mutations in AML: review of current knowledge and evidenceN Daver, RF Schlenk, NH Russell, MJ LevisLeukemia 33 (2), 299-312, 20198832019
3-)
Assessment of minimal residual disease in standard-risk AMLA Ivey, RK Hills, MA Simpson, JV Jovanovic, A Gilkes, A Grech, Y Patel, ...New England Journal of Medicine 374 (5), 422-433, 20168692016
4-)
Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trialAK Burnett, RK Hills, D Milligan, L Kjeldsen, J Kell, NH Russell, JAL Yin, ...Journal of clinical oncology 29 (4), 369-377, 20117572011
5-)
Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myelomaBA Walker, EM Boyle, CP Wardell, A Murison, DB Begum, NM Dahir, ...Journal of clinical oncology 33 (33), 3911-3920, 20156522015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept